Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 76
1999 69
2000 82
2001 75
2002 88
2003 107
2004 135
2005 182
2006 236
2007 345
2008 435
2009 255
2010 259
2011 286
2012 316
2013 352
2014 300
2015 357
2016 330
2017 341
2018 367
2019 293
2020 314
2021 267
2022 247
2023 266
2024 139

Text availability

Article attribute

Article type

Publication date

Search Results

5,300 results

Results by year

Filters applied: . Clear all
Page 1
Nanodelivery systems for cutaneous melanoma treatment.
Pereira I, Monteiro C, Pereira-Silva M, Peixoto D, Nunes C, Reis S, Veiga F, Hamblin MR, Paiva-Santos AC. Pereira I, et al. Eur J Pharm Biopharm. 2023 Mar;184:214-247. doi: 10.1016/j.ejpb.2023.02.002. Epub 2023 Feb 10. Eur J Pharm Biopharm. 2023. PMID: 36773725 Free article. Review.
Letter to the Editor.
Dewulf L, Elliott J. Dewulf L, et al. Eur J Pharm Biopharm. 2022 Dec;181:102-103. doi: 10.1016/j.ejpb.2022.10.014. Epub 2022 Nov 9. Eur J Pharm Biopharm. 2022. PMID: 36334839 No abstract available.
Biomimetic nanotherapeutics: Employing nanoghosts to fight melanoma.
Bagasariya D, Charankumar K, Shah S, Famta P, Khatri DK, Singh Raghuvanshi R, Bala Singh S, Srivastava S. Bagasariya D, et al. Eur J Pharm Biopharm. 2022 Aug;177:157-174. doi: 10.1016/j.ejpb.2022.06.014. Epub 2022 Jul 3. Eur J Pharm Biopharm. 2022. PMID: 35787429 Review.
Corrigendum to "Evaluation the injectability of injectable microparticle delivery systems on the basis of injection force and discharged rate" [Eur. J. Pharm. Biopharm. 190 (2023) 58-72].
Zhao C, Zhu Z, Cao X, Pan F, Li F, Xue M, Guo Y, Zhao Y, Zeng J, Liu Y, Yang Z, Liu Y, Ren F, Feng L. Zhao C, et al. Eur J Pharm Biopharm. 2024 Jan;194:170. doi: 10.1016/j.ejpb.2023.09.013. Epub 2023 Dec 15. Eur J Pharm Biopharm. 2024. PMID: 38103996 No abstract available.
Corrigendum to "DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition" [Eur. J. Pharm. Biopharm. 122 (2018) 37-48].
Bakrania AK, Variya BC, Rathod LV, Patel SS. Bakrania AK, et al. Eur J Pharm Biopharm. 2024 Feb;195:114172. doi: 10.1016/j.ejpb.2023.114172. Epub 2023 Dec 22. Eur J Pharm Biopharm. 2024. PMID: 38142168 No abstract available.
5,300 results